Agios Pharmaceuticals Inc (AGIO)
55.68
+0.14
(+0.25%)
USD |
NASDAQ |
Nov 22, 16:00
55.66
-0.02
(-0.03%)
After-Hours: 20:00
Agios Pharmaceuticals Market Cap: 3.175B for Nov. 22, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| November 22, 2024 | 3.175B |
| November 21, 2024 | 3.167B |
| November 20, 2024 | 3.115B |
| November 19, 2024 | 3.103B |
| November 18, 2024 | 3.016B |
| November 15, 2024 | 3.067B |
| November 14, 2024 | 3.159B |
| November 13, 2024 | 3.342B |
| November 12, 2024 | 3.366B |
| November 11, 2024 | 3.448B |
| November 08, 2024 | 3.368B |
| November 07, 2024 | 3.141B |
| November 06, 2024 | 2.942B |
| November 05, 2024 | 2.663B |
| November 04, 2024 | 2.557B |
| November 01, 2024 | 2.559B |
| October 31, 2024 | 2.534B |
| October 30, 2024 | 2.640B |
| October 29, 2024 | 2.671B |
| October 28, 2024 | 2.628B |
| October 25, 2024 | 2.571B |
| October 24, 2024 | 2.571B |
| October 23, 2024 | 2.528B |
| October 22, 2024 | 2.588B |
| October 21, 2024 | 2.604B |
| Date | Value |
|---|---|
| October 18, 2024 | 2.594B |
| October 17, 2024 | 2.517B |
| October 16, 2024 | 2.492B |
| October 15, 2024 | 2.397B |
| October 14, 2024 | 2.354B |
| October 11, 2024 | 2.432B |
| October 10, 2024 | 2.385B |
| October 09, 2024 | 2.332B |
| October 08, 2024 | 2.309B |
| October 07, 2024 | 2.315B |
| October 04, 2024 | 2.356B |
| October 03, 2024 | 2.313B |
| October 02, 2024 | 2.383B |
| October 01, 2024 | 2.422B |
| September 30, 2024 | 2.533B |
| September 27, 2024 | 2.595B |
| September 26, 2024 | 2.734B |
| September 25, 2024 | 2.789B |
| September 24, 2024 | 2.651B |
| September 23, 2024 | 2.603B |
| September 20, 2024 | 2.648B |
| September 19, 2024 | 2.696B |
| September 18, 2024 | 2.591B |
| September 17, 2024 | 2.599B |
| September 16, 2024 | 2.584B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
934.70M
Minimum
Jun 14 2022
3.988B
Maximum
Feb 11 2021
2.234B
Average
2.026B
Median
Market Cap Benchmarks
| Pfizer Inc | 145.36B |
| Zimmer Biomet Holdings Inc | 21.94B |
| NovaBay Pharmaceuticals Inc | 3.327M |
| Palatin Technologies Inc | 18.77M |
| iBio Inc | 24.15M |
Market Cap Related Metrics
| PE Ratio | 4.901 |
| PS Ratio | 96.36 |
| Price to Book Value | 1.952 |
| Price | 55.68 |
| Earnings Yield | 20.40% |